ResearcherCentral South UniversityActive in the last 2 years
Chaohui Zuo
Matched on ORCID iD 0000-0002-0835-7464; OpenAlex author ID A5068083936. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 1, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 34
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 10
- Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.isci.2025.113053↗
- Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma. Last author DOI 10.1002/ijc.34195↗
- Effect of exosomes as drug carriers in chemotherapy of pancreatic cancer. First author DOI 10.11817/j.issn.1672-7347.2023.220439↗
- Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimurium. Co-author DOI 10.1016/j.ymthe.2021.08.023↗
- Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer. Last author DOI 10.1002/cam4.2633↗
- [Clinical significance of exosomal miR-1231 in pancreatic cancer]. Last author DOI 10.3760/cma.j.issn.0253-3766.2019.01.008↗
- Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3 / NF-kB and L1CAM activities. Co-author DOI 10.1016/j.pan.2018.02.006↗
- Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Co-author DOI 10.1038/ng.3568↗
- Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. Co-author DOI 10.1093/carcin/bgt004↗
- Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Co-author DOI 10.1038/ng.1020↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Biaoming Xu · 3 shared papers, 2023–2025 · strength 0.87
- Paper Effect of exosomes as drug carriers in chemotherapy of pancreatic cancer. DOI 10.11817/j.issn.1672-7347.2023.220439↗
- Paper Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113053↗
- Paper Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma. DOI 10.1002/ijc.34195↗
- Wenzhi Tan · 2 shared papers, 2022–2025 · strength 0.40
- Paper Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113053↗
- Paper Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimurium. DOI 10.1016/j.ymthe.2021.08.023↗
- Shun Deng · 1 shared paper, 2025 · strength 0.25
- S Shang · 2 shared papers, 2019 · strength 0.18
- Jung‐Joon Min · 1 shared paper, 2022 · strength 0.16
- Yu Zhang · 1 shared paper, 2019 · strength 0.09
- S L Chen · 1 shared paper, 2019 · strength 0.09
- Xu Che · 3 shared papers, 2011–2016 · strength 0.08
- Paper Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. DOI 10.1038/ng.3568↗
- Paper Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. DOI 10.1093/carcin/bgt004↗
- Paper Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese popul… DOI 10.1038/ng.1020↗
- Dianke Yu · 3 shared papers, 2011–2016 · strength 0.08
- Paper Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. DOI 10.1038/ng.3568↗
- Paper Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. DOI 10.1093/carcin/bgt004↗
- Paper Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese popul… DOI 10.1038/ng.1020↗
- Xiaoping Miao · 3 shared papers, 2011–2016 · strength 0.08
- Paper Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. DOI 10.1038/ng.3568↗
- Paper Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. DOI 10.1093/carcin/bgt004↗
- Paper Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese popul… DOI 10.1038/ng.1020↗
- Chen Hsuan Wu · 3 shared papers, 2011–2016 · strength 0.08
- Paper Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. DOI 10.1038/ng.3568↗
- Paper Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. DOI 10.1093/carcin/bgt004↗
- Paper Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese popul… DOI 10.1038/ng.1020↗
- Guoliang Jiang · 3 shared papers, 2011–2016 · strength 0.08
- Paper Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. DOI 10.1038/ng.3568↗
- Paper Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. DOI 10.1093/carcin/bgt004↗
- Paper Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese popul… DOI 10.1038/ng.1020↗
- Xianjun Yu · 3 shared papers, 2011–2016 · strength 0.08
- Paper Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. DOI 10.1038/ng.3568↗
- Paper Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. DOI 10.1093/carcin/bgt004↗
- Paper Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese popul… DOI 10.1038/ng.1020↗
- Dongxin Lin · 3 shared papers, 2011–2016 · strength 0.08
- Paper Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. DOI 10.1038/ng.3568↗
- Paper Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. DOI 10.1093/carcin/bgt004↗
- Paper Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese popul… DOI 10.1038/ng.1020↗
- Zhuo Liu · 1 shared paper, 2018 · strength 0.08
- Chengfeng Wang · 2 shared papers, 2011–2016 · strength 0.06
- Chunyou Wang · 2 shared papers, 2011–2016 · strength 0.06
- Jiang Chang · 2 shared papers, 2011–2016 · strength 0.06
- Zhaoshen Li · 1 shared paper, 2016 · strength 0.04
- Jian Zheng · 1 shared paper, 2016 · strength 0.04
- Xudong Huang · 1 shared paper, 2016 · strength 0.04
- Xianghong Yang · 1 shared paper, 2016 · strength 0.04
- Jun Gao · 2 shared papers, 2011–2013 · strength 0.04
- Yi Liu · 1 shared paper, 2013 · strength 0.02
- Tingting Wu · 1 shared paper, 2013 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.